HEDENA HEALTH
207 LONDON ROAD, HEADINGTON, OXFORD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 21 | 27 | 77.8% | |
| HF 4 | 2011 | 20 | 26 | 76.9% | |
| HF 4 | 2012 | 23 | 30 | 76.7% | |
| HF 4 | 2013 | 21 | 23 | 91.3% | |
| HF004 | 2014 | 11 | 13 | 84.6% | |
| HF004 | 2015 | 17 | 19 | 89.5% | |
| HF004 | 2016 | 27 | 34 | 79.4% | |
| HF004 | 2017 | 35 | 43 | 81.4% | |
| HF004 | 2018 | 37 | 40 | 92.5% | |
| HF004 | 2019 | 44 | 52 | 84.6% | |
| HF004 | 2020 | 45 | 54 | 83.3% | |
| HF006 | 2021 | 61 | 83 | 73.5% | |
| HF006 | 2022 | 63 | 65 | 96.9% | |
| HF006 | 2023 | 75 | 79 | 94.9% |
